Article
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.
Molecules (Basel, Switzerland) - 14 Oct 2021
Sobhani Navid, Roviello Giandomenico, D'Angelo Alberto, Roudi Raheleh, Neeli Praveen Kumar, Generali Daniele
Abstract excerpt
Importance: The protein p53 is an unequivocal tumor suppressor that is altered in half of all cancers. The immune system produces systemic p53 autoantibodies (p53 Abs) in many cancer patients. Objective: This systemic review and meta-analysis focuses on the prognostic value of p53 Abs expressed in the serum of patients with solid tumors. Data Sources: All the clinical investigations were searched on PubMed from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
